Adrian Gottschalk

CEO

Board Member

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

FHTX

Current role

CEO, Board Member

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Foghorn Therapeutics Inc. (FHTX)	President and Chief Executive Officer	$638,000	—	—	$1,334,037	$385,990	$3,000	$2,361,027
2024	Foghorn Therapeutics Inc. (FHTX)	President and Chief Executive Officer	$601,500	—	—	$673,861	$281,201	$3,000	$1,559,562
2023	Foghorn Therapeutics Inc. (FHTX)	President and Chief Executive Officer	$579,000	—	—	$1,719,292	$202,650	$3,000	$2,503,942
2022	Foghorn Therapeutics Inc. (FHTX)	President and Chief Executive Officer	$575,000	—	—	$4,645,819	$215,625	—	$5,436,444
2021	Foghorn Therapeutics Inc. (FHTX)	President and Chief Executive Officer	$540,000	—	—	$3,370,482	$405,000	—	$4,315,482
2020	Foghorn Therapeutics Inc. (FHTX)	President and Chief Executive Officer	$478,950	—	—	$1,834,007	$311,318	—	$2,624,275
2019	Foghorn Therapeutics Inc. (FHTX)	President and Chief Executive Officer	$465,000	—	—	$642,918	$197,625	—	$1,305,543

No earnings-call appearances or filed executive changes recorded yet.